Novartis

Advertisement
Rob DillardVideos | April 28, 2023
DocWire News recently sat down with Shephard Mpofu, M.D., SVP, Chief Medical Officer, Novartis Gene Therapies, to ...
View More
Kaitlyn D’OnofrioRheumatology | September 11, 2023
Pharmaceutical giant Amgen won a ruling in a federal appeals court today against Novartis AG’s Sandoz, preventing the ...
Kaitlyn D’OnofrioRheumatology | August 29, 2019
The U.S. Food and Drug Administration (FDA) has expanded the indication of Eli Lilly and Company’s Taltz (ixekizumab) ...
Kaitlyn D’OnofrioRheumatology | August 16, 2019
Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, read about ...
Kaitlyn D’OnofrioRheumatology | August 16, 2019
A U.S. judge ruled in favor of Amgen on the validity of two patents pertaining to the company’s drug Enbrel ...
DocWire News EditorsTelemedicine | May 2, 2023
Pear Therapeutics has recently teamed up with Sandoz, a Novartis branch, to release reSET, the first and only ...
DocWire News EditorsFuture of Medicine | April 25, 2023
This week the Swiss pharmaceutical company Novartis, which has been moving into the rare disease market, said it that ...
Kaitlyn D’OnofrioCardiology | October 22, 2018
The U.S. Food and Drug Administration (FDA) has rejected canakinumab to be used to reduce the risk of cardiovascular ...
Advertisement
Advertisement
Advertisement
Latest News

June 21, 2024